Quarterly Result11 Nov 2026, 07:31 pm
Novelix Pharmaceuticals Submits Unaudited Financial Results
AI Summary
Novelix Pharmaceuticals Ltd has submitted its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results during a meeting held on November 11, 2026. The results were prepared in accordance with Indian Accounting Standard 34 and have undergone a limited review by the auditors, CVS Balachandra Rao & Co. The company has also made this information available on its website.
Key Highlights
- Unaudited financial results for Q2 FY27 submitted.
- Results cover the quarter and half-year ended September 30, 2026.
- Board of Directors approved the financial results.
- Limited review report from auditors is included.
- Information is available on the company website.
Price Impact
More from NOVELIX